Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis

ConclusionsMaximum SUV across all involved organ-systems of the chest and upper abdomen, not that of the heart alone, could be a predictor of treatment course of steroid therapy at 6  months in patients with active cardiac sarcoidosis.
Source: EJNMMI Research - Category: Radiology Source Type: research